Drug
TMF
Total Trials
2
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph early_phase_1
1
50%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Early Phase 1First-in-human
1(100.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Other(1)
Detailed Status
Not yet recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (100.0%)
Trials by Status
not_yet_recruiting150%
unknown150%
Recent Activity
0 active trials
Showing 2 of 2
not_yet_recruitingearly_phase_1
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
NCT07553767
unknown
The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment
NCT05755776
Clinical Trials (2)
Showing 2 of 2 trials
NCT07553767Early Phase 1
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
NCT05755776
The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment
All 2 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 2